Pages that link to "Q33623571"

The following pages link to Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model (Q33623571):

Displaying 20 items.

• Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease (Q26865498) (← links)
• Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats (Q28569530) (← links)
• Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells (Q33731221) (← links)
• Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines (Q34016378) (← links)
• The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes (Q35041174) (← links)
• Significant mobilization of both conventional and regulatory T cells with AMD3100. (Q35623657) (← links)
• WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. (Q36079791) (← links)
• Pre-treatment of allogeneic bone marrow recipients with the CXCR4 antagonist AMD3100 transiently enhances hematopoietic chimerism without promoting donor-specific skin allograft tolerance (Q36157297) (← links)
• Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice (Q36722804) (← links)
• Using quantitative real-time PCR to determine donor cell engraftment in a competitive murine bone marrow transplantation model (Q36754210) (← links)
• Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery (Q37185324) (← links)
• G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses (Q37309938) (← links)
• Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution. (Q37639107) (← links)
• Stromal-Derived Factor-1/CXCR4Signaling: Indispensable Role in Homing and Engraftment of Hematopoietic Stem Cells in Bone Marrow (Q37824153) (← links)
• Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation (Q38105635) (← links)
• Physiology and pharmacology of plerixafor (Q38157897) (← links)
• MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. (Q39930681) (← links)
• Is the post-transplantation treatment with AMD beneficial? (Q42139478) (← links)
• Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF-1. (Q42241247) (← links)
• The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling (Q55463049) (← links)